| http://www.w3.org/ns/prov#value | - tering to a patient a therapeutically effective amount of a pharmaceutical composition comprising a denatured collagen type-IV selective antagonist of the invention. [0089] The invention provides a method for inhibiting angiogenesis, tumor growth, metastasis, arthritis, inflammatory diseases and other diseases or conditions associated with cellular interactions with denatured collagen-type-IV in t
|
